Deerfield Management Company, L.P. (Series C) Emergent Bio Solutions Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 14,058 shares of EBS stock, worth $65,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,058
Previous 75,642
81.42%
Holding current value
$65,510
Previous $631,000
78.76%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
173Shares Held
36.7MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$17.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$14.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$9.96 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$9.15 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$7.18 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $232M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...